Search Results - "MAGNE TVEIT, Kjell"

A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer by Gustavsson, Bengt, Carlsson, Göran, Machover, David, Petrelli, Nicholas, Roth, Arnaud, Schmoll, Hans-Joachim, Tveit, Kjell-Magne, Gibson, Fernando

“…Abstract Herein we present a historical review of the development of systemic chemotherapy for colorectal cancer (CRC) in the metastatic and adjuvant treatment…”
Get full text

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study by MAGNE TVEIT, Kjell, GUREN, Tormod, FOKSTUEN, Tone, HANSEN, Flemming, HOFSLI, Eva, BIRKEMEYER, Elke, JOHNSSON, Anders, STARKHAMMAR, Hans, YILMAZ, Mette Karen, KELDSEN, Nina, BERIT ERDAL, Anne, DAJANI, Olav, GLIMELIUS, Bengt, DAHL, Olav, CHRISTOFFERSEN, Thoralf, PFEIFFER, Per, SORBYE, Halfdan, PYRHONEN, Seppo, SIGURDSSON, Fridbjorn, KURE, Elin, IKDAHL, Tone, SKOVLUND, Eva

“…The NORDIC-VII multicenter phase III trial investigated the efficacy of cetuximab when added to bolus fluorouracil/folinic acid and oxaliplatin (Nordic FLOX),…”
Get full text

Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer by Bruheim, Kjersti, M.D, Guren, Marianne G., M.D., Ph.D, Skovlund, Eva, Ph.D, Hjermstad, Marianne J., Ph.D, Dahl, Olav, M.D., Ph.D, Frykholm, Gunilla, M.D., Ph.D, Carlsen, Erik, M.D., Ph.D, Tveit, Kjell Magne, M.D., Ph.D

“…Purpose There is little knowledge on long-term morbidity after radiotherapy (50 Gy) and total mesorectal excision for rectal cancer. Therefore, late effects on…”
Get full text

Late Patient-Reported Toxicity After Preoperative Radiotherapy or Chemoradiotherapy in Nonresectable Rectal Cancer: Results From a Randomized Phase III Study by Brændengen, Morten, M.D, Tveit, Kjell Magne, Ph.D, Bruheim, Kjersti, Ph.D, Cvancarova, Milada, M.Sc, Berglund, Åke, Ph.D, Glimelius, Bengt, Ph.D

“…Purpose Preoperative chemoradiotherapy (CRT) is superior to radiotherapy (RT) in locally advanced rectal cancer, but the survival gain is limited. Late…”
Get full text

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer by Mezheyeuski, Artur, Bradic Lindh, Maja, Guren, Tormod Kyrre, Dragomir, Anca, Pfeiffer, Per, Kure, Elin H, Ikdahl, Tone, Skovlund, Eva, Corvigno, Sara, Strell, Carina, Pietras, Kristian, Ponten, Fredrik, Mulder, Jan, Qvortrup, Camilla, Portyanko, Anna, Tveit, Kjell Magne, Glimelius, Bengt, Sorbye, Halfdan, Östman, Arne

“…Perivascular cells (PC) were recently implied as regulators of metastasis and immune cell activity. Perivascular heterogeneity in clinical samples, and…”
Get full text

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome by Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre

“…Background Mutation status of RAS and BRAF , as well as serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are biomarkers…”
Get full text

Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy by Smedman, Tor Magnus, Guren, Tormod Kyrre, Tveit, Kjell Magne, Thomsen, Maria, Andersen, Marit Helen, Line, Pål-Dag, Dueland, Svein

“…Liver transplantation (LT) for patients with non-resectable colorectal liver metastases (CRLM) offers improved survival and has gained increased interest…”
Get full text

Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer by Hamfjord, Julian, Guren, Tormod Kyrre, Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per, Dajani, Olav, Lingjærde, Ole Christian, Tveit, Kjell Magne, Pallisgaard, Niels, Spindler, Karen‐Lise Garm, Kure, Elin H.

“…Detection of tumour‐specific circulating cell‐free DNA in plasma (ctDNA) fails in a significant number of cases depending on the clinical context. The primary…”
Get full text

Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis by Adams, Richard, Goey, Kaitlyn, Chibaudel, Benoist, Koopman, Miriam, Punt, Cornelis, Arnold, Dirk, Hinke, Axel, Hegewisch-Becker, Susanna, de Gramont, Aimery, Labianca, Roberto, Diaz Rubio, Eduardo, Magne Tveit, Kjell, Wasan, Harpreet, Kaplan, Richard, Brown, Louise, Maughan, Tim, Fisher, David

“…•Survival in advanced colorectal cancer is not affected by the use of an intermittent systemic anti-cancer therapy strategy, whether that be a complete break…”
Get full text

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer by Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S, Kure, Elin H, Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre

“…The aim was to explore the prognostic significance of IL-6 and markers of systemic inflammatory response (SIR), in particular C-reactive protein (CRP), in…”
Get full text

Sexual Function in Males After Radiotherapy for Rectal Cancer by Bruheim, Kjersti, M.D, Guren, Marianne G., M.D., Ph.D, Dahl, Alv A., M.D., Ph.D, Skovlund, Eva, Ph.D, Balteskard, Lise, M.D., Ph.D, Carlsen, Erik, M.D., Ph.D, Fosså, Sophie D., M.D., Ph.D, Tveit, Kjell Magne, M.D., Ph.D

“…Purpose Knowledge of sexual problems after pre- or postoperative radiotherapy (RT) with 50 Gy for rectal cancer is limited. In this study, we aimed to compare…”
Get full text

Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study by Tarpgaard, Line S, Guren, Tormod K, Glimelius, Bengt, Christensen, Ib J, Pfeiffer, Per, Kure, Elin H, Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S, Tveit, Kjell Magne

“…We aim to test the hypothesis that high plasma YKL-40 is associated with short progression-free survival (PFS) and overall survival (OS) in patients with…”
Get full text

Radiotherapy for Rectal Cancer Is Associated With Reduced Serum Testosterone and Increased FSH and LH by Bruheim, Kjersti, M.D, Svartberg, Johan, M.D., Ph.D, Carlsen, Erik, M.D., Ph.D, Dueland, Svein, M.D., Ph.D, Haug, Egil, M.D., Ph.D, Skovlund, Eva, Ph.D, Tveit, Kjell Magne, M.D., Ph.D, Guren, Marianne G., M.D., Ph.D

“…Purpose It is known that scattered radiation to the testes during pelvic radiotherapy can affect fertility, but there is little knowledge on its effects on…”
Get full text

Multicenter Phase II Study of Nordic Fluorouracil and Folinic Acid Bolus Schedule Combined With Oxaliplatin As First-Line Treatment of Metastatic Colorectal Cancer by SØRBYE, Halfdan, GLIMELIUS, Bengt, BERGLUND, Ake, FOKSTUEN, Tone, TVEIT, Kjell Magne, BROENDENGEN, Marten, ØGREID, Dagfinn, DAHL, Olav

“…This Nordic multicenter phase II study evaluated the efficacy and safety of oxaliplatin combined with the Nordic bolus schedule of fluorouracil (FU) and…”
Get full text

Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group by Glimelius, Bengt, Dahl, Olav, Cedermark, Björn, Jakobsen, Anders, Bentzen, Søren M, Starkhammar, Hans, Grönberg, Henrik, Hultborn, Ragnar, Albertsson, Maria, Påhlman, Lars, Tveit, Kjell-Magne

“…Due to uncertainties regarding clinically meaningful gains from adjuvant chemotherapy after colorectal cancer surgery, several Nordic Groups in the early 1990s…”
Get more information

Radiation therapy induced changes in male sex hormone levels in rectal cancer patients by Dueland, Svein, Grønlie Guren, Marianne, Rune Olsen, Dag, Poulsen, Jan Peter, Magne Tveit, Kjell

“…Background and purpose:To determine the effect of curative radiation therapy (46–50 Gy) on the sex hormone levels in male rectal cancer patients. Materials and…”
Get full text

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer by Sørbye, Halfdan, Berglund, Ake, Tveit, Kjell Magne, Ogreid, Dagfinn, Wanderås, Eva Hoff, Wentzel-Larsen, Tore, Dahl, Olav, Glimelius, Bengt

“…Two consecutive studies have evaluated the efficacy of oxaliplatin combined with the Nordic bolus schedule of 5-fluorouracil and folinic acid as first-line…”
Get more information

Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Randomized Clinical Trial by Holme, Øyvind, Løberg, Magnus, Kalager, Mette, Bretthauer, Michael, Hernán, Miguel A, Aas, Eline, Eide, Tor J, Skovlund, Eva, Schneede, Jørn, Tveit, Kjell Magne, Hoff, Geir

“…IMPORTANCE: Colorectal cancer is a major health burden. Screening is recommended in many countries. OBJECTIVE: To estimate the effectiveness of flexible…”
Get full text

Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer by Guren, Marianne Grønlie, Schneede, Jørn, Tveit, Kjell Magne, Ueland, Per Magne, Nexø, Ebba, Dueland, Svein

“…The aim of the study was to investigate whether pelvic radiotherapy for rectal cancer had a negative impact on cobalamin status. Consecutive patients receiving…”
Get more information

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial by Holme, Øyvind, Løberg, Magnus, Kalager, Mette, Bretthauer, Michael, Hernán, Miguel A, Aas, Eline, Eide, Tor J, Skovlund, Eva, Lekven, Jon, Schneede, Jörn, Tveit, Kjell Magne, Vatn, Morten, Ursin, Giske, Hoff, Geir

“…The long-term effects of sigmoidoscopy screening on colorectal cancer (CRC) incidence and mortality in women and men are unclear. To determine the…”
Get full text